title: Vinculin modulation of paxillin-FAK interactions regulates ERK to control survival and motility.
abstract: Cells lacking vinculin are highly metastatic and motile. The reasons for this finding have remained unclear. Both enhanced survival and motility are critical to metastasis. Here, we show that vinculin null (vin-/-) cells and cells expressing a vinculin Y822F mutant have increased survival due to up-regulated activity of extracellular signal-regulated kinase (ERK). This increase is shown to result from vinculin's modulation of paxillin-FAK interactions. A vinculin fragment (amino acids 811-1066) containing the paxillin binding site restored apoptosis and suppressed ERK activity in vin-/- cells. Both vinY822F and vin-/- cells exhibit increased interaction between paxillin and focal adhesion kinase (FAK) and increased paxillin and FAK phosphorylation. Transfection with paxillin Y31FY118F dominant-negative mutant in these cells inhibits ERK activation and restores apoptosis. The enhanced motility of vin-/- and vinY822F cells is also shown to be due to a similar mechanism. Thus, vinculin regulates survival and motility via ERK by controlling the accessibility of paxillin for FAK interaction.
authors.affiliation: Department of Cell Biology, The Scripps Research Institute, La Jolla, CA 92037, USA.
authors.forename: M Cecilia
authors.initials: MC
authors.lastname: Subauste
authors.forename: Olivier
authors.initials: O
authors.lastname: Pertz
authors.forename: Eileen D
authors.initials: ED
authors.lastname: Adamson
authors.forename: Christopher E
authors.initials: CE
authors.lastname: Turner
authors.forename: Sachiko
authors.initials: S
authors.lastname: Junger
authors.forename: Klaus M
authors.initials: KM
authors.lastname: Hahn
mesh_terms: D000818:Animals; D017209:Apoptosis / Q000235:genetics; D001665:Binding Sites / Q000235:genetics; D002448:Cell Adhesion / Q000235:genetics; D002465:Cell Movement / Q000502:physiology*; D002470:Cell Survival / Q000235:genetics; D003598:Cytoskeletal Proteins / Q000235:genetics / Q000378:metabolism*; D051417:Focal Adhesion Kinase 1; D051416:Focal Adhesion Protein-Tyrosine Kinases; D051379:Mice; D020928:Mitogen-Activated Protein Kinases / Q000378:metabolism*; D009154:Mutation / Q000235:genetics; D009362:Neoplasm Metastasis / Q000235:genetics; D014411:Neoplastic Stem Cells; D051419:Paxillin; D010446:Peptide Fragments / Q000235:genetics / Q000378:metabolism; D010750:Phosphoproteins / Q000235:genetics / Q000378:metabolism*; D010766:Phosphorylation; D011505:Protein-Tyrosine Kinases / Q000378:metabolism*; D014162:Transfection; D015854:Up-Regulation / Q000235:genetics; D016596:Vinculin / Q000235:genetics / Q000378:metabolism / Q000502:physiology*
chemical_list: D003598:Cytoskeletal Proteins; D051419:Paxillin; D010446:Peptide Fragments; D010750:Phosphoproteins; C496062:Pxn protein, mouse; D016596:Vinculin; D011505:Protein-Tyrosine Kinases; D051417:Focal Adhesion Kinase 1; D051416:Focal Adhesion Protein-Tyrosine Kinases; C496051:Ptk2 protein, mouse; D020928:Mitogen-Activated Protein Kinases